Your browser doesn't support javascript.
loading
The multi-lineage transcription factor ISL1 controls cardiomyocyte cell fate through interaction with NKX2.5.
Maven, Bonnie E J; Gifford, Casey A; Weilert, Melanie; Gonzalez-Teran, Barbara; Hüttenhain, Ruth; Pelonero, Angelo; Ivey, Kathryn N; Samse-Knapp, Kaitlen; Kwong, Wesley; Gordon, David; McGregor, Michael; Nishino, Tomohiro; Okorie, Eyuche; Rossman, Sage; Costa, Mauro W; Krogan, Nevan J; Zeitlinger, Julia; Srivastava, Deepak.
Afiliación
  • Maven BEJ; Gladstone Institutes, San Francisco, CA, USA; Developmental and Stem Cell Biology PhD Program, University of California, San Francisco, San Francisco, CA, USA; Roddenberry Center for Stem Cell Biology at Gladstone, San Francisco, CA, USA.
  • Gifford CA; Gladstone Institutes, San Francisco, CA, USA; Roddenberry Center for Stem Cell Biology at Gladstone, San Francisco, CA, USA.
  • Weilert M; Stowers Institute for Medical Research, Kansas City, MO, USA.
  • Gonzalez-Teran B; Gladstone Institutes, San Francisco, CA, USA; Roddenberry Center for Stem Cell Biology at Gladstone, San Francisco, CA, USA.
  • Hüttenhain R; Gladstone Institutes, San Francisco, CA, USA; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, San Francisco, CA, USA.
  • Pelonero A; Gladstone Institutes, San Francisco, CA, USA; Roddenberry Center for Stem Cell Biology at Gladstone, San Francisco, CA, USA.
  • Ivey KN; Gladstone Institutes, San Francisco, CA, USA; Roddenberry Center for Stem Cell Biology at Gladstone, San Francisco, CA, USA.
  • Samse-Knapp K; Gladstone Institutes, San Francisco, CA, USA; Roddenberry Center for Stem Cell Biology at Gladstone, San Francisco, CA, USA.
  • Kwong W; Gladstone Institutes, San Francisco, CA, USA; Roddenberry Center for Stem Cell Biology at Gladstone, San Francisco, CA, USA.
  • Gordon D; Gladstone Institutes, San Francisco, CA, USA; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, San Francisco, CA, USA.
  • McGregor M; Gladstone Institutes, San Francisco, CA, USA; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, San Francisco, CA, USA.
  • Nishino T; Gladstone Institutes, San Francisco, CA, USA; Roddenberry Center for Stem Cell Biology at Gladstone, San Francisco, CA, USA.
  • Okorie E; Gladstone Institutes, San Francisco, CA, USA; Roddenberry Center for Stem Cell Biology at Gladstone, San Francisco, CA, USA.
  • Rossman S; Gladstone Institutes, San Francisco, CA, USA; Roddenberry Center for Stem Cell Biology at Gladstone, San Francisco, CA, USA.
  • Costa MW; Gladstone Institutes, San Francisco, CA, USA; Roddenberry Center for Stem Cell Biology at Gladstone, San Francisco, CA, USA.
  • Krogan NJ; Gladstone Institutes, San Francisco, CA, USA; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, San Francisco, CA, USA.
  • Zeitlinger J; Stowers Institute for Medical Research, Kansas City, MO, USA; Department of Pathology and Laboratory Medicine, University of Kansas School of Medicine, Kansas City, KS, USA.
  • Srivastava D; Gladstone Institutes, San Francisco, CA, USA; Roddenberry Center for Stem Cell Biology at Gladstone, San Francisco, CA, USA; Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA; Department of Pediatrics, UCSF School of Medicine, San Francisco, C
Stem Cell Reports ; 18(11): 2138-2153, 2023 11 14.
Article en En | MEDLINE | ID: mdl-37863045

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Células Madre Pluripotentes Inducidas Límite: Humans Idioma: En Revista: Stem Cell Reports Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Células Madre Pluripotentes Inducidas Límite: Humans Idioma: En Revista: Stem Cell Reports Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos